Medtronic Ordered to Pay Over $380 Million in Monopolization Suit

A federal jury in California ordered Medtronic Inc. to pay more than $380 million in damages for monopolizing the market for leading electrosurgical devices, according to a person familiar with the matter.

Medtronic said in a statement that it is disappointed with the jury’s verdict and plans to appeal. The case was brought by competitor Applied Medical Resources Corp.

“We remain confident that our business practices deliver the best product to our customers and at the value they expect,” Medtronic said. “Surgeons choose Medtronic’s LigaSure device time and again because it outperforms Applied’s Voyant.”

Medtronic is a medical device company ...